Community Anaphylaxis.

This article provides a comparative overview of anaphylaxis management in the community, with a focus on the home, restaurants, school, flight, and workplace settings in Canada, The United State of America, and Europe. While early recognition and prompt epinephrine use are critical, barriers such as underuse of epinephrine auto-injectors, inadequate training, and inconsistent legislation contribute to morbidity and mortality. We conducted a comparative narrative review of anaphylaxis management across community settings, synthesizing evidence from international guidelines, epidemiologic studies, and legislative frameworks. Adapting effective models from school programs to high-risk settings, alongside improved public education, can reduce disparities and improve outcomes.